Ganjun Kang

422 total citations
21 papers, 296 citations indexed

About

Ganjun Kang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ganjun Kang has authored 21 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Ganjun Kang's work include Chemokine receptors and signaling (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Esophageal and GI Pathology (3 papers). Ganjun Kang is often cited by papers focused on Chemokine receptors and signaling (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Esophageal and GI Pathology (3 papers). Ganjun Kang collaborates with scholars based in China. Ganjun Kang's co-authors include Songping Xie, Wanli Jiang, Jie Huang, Weidong Hu, Jingping Yuan, Honglin Yan, Li Xu, Zhi Zeng, Wanzhou Xu and Jie Xiong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Cellular Physiology.

In The Last Decade

Ganjun Kang

21 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ganjun Kang China 10 105 75 66 51 50 21 296
Pei-Ying Wu Taiwan 12 166 1.6× 99 1.3× 38 0.6× 46 0.9× 46 0.9× 21 352
You Zou China 12 182 1.7× 59 0.8× 73 1.1× 70 1.4× 35 0.7× 25 396
Zhenhua Zhu China 11 145 1.4× 25 0.3× 40 0.6× 48 0.9× 54 1.1× 25 308
Panagiota Tsioli Greece 9 126 1.2× 112 1.5× 76 1.2× 21 0.4× 53 1.1× 10 317
Jieli Han China 8 102 1.0× 165 2.2× 73 1.1× 35 0.7× 97 1.9× 8 369
Eui‐Young So United States 12 152 1.4× 96 1.3× 47 0.7× 27 0.5× 163 3.3× 17 397
Daqian Gu China 7 82 0.8× 119 1.6× 55 0.8× 16 0.3× 100 2.0× 8 298
Moe Matsumoto Japan 6 120 1.1× 32 0.4× 113 1.7× 37 0.7× 52 1.0× 26 306
Zhengrong Mao China 9 104 1.0× 92 1.2× 23 0.3× 27 0.5× 89 1.8× 16 385
Wenfeng Zhang China 12 154 1.5× 54 0.7× 38 0.6× 19 0.4× 26 0.5× 39 313

Countries citing papers authored by Ganjun Kang

Since Specialization
Citations

This map shows the geographic impact of Ganjun Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ganjun Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ganjun Kang more than expected).

Fields of papers citing papers by Ganjun Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ganjun Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ganjun Kang. The network helps show where Ganjun Kang may publish in the future.

Co-authorship network of co-authors of Ganjun Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Ganjun Kang. A scholar is included among the top collaborators of Ganjun Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ganjun Kang. Ganjun Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bao, Yan, Ganjun Kang, Xiaoyan Wu, et al.. (2023). Mediastinal parathyroid carcinoma: a case report and review of the literature. BMC Endocrine Disorders. 23(1). 130–130. 2 indexed citations
2.
Zhang, Renquan, Wanli Jiang, Zheng Tang, et al.. (2023). Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-β1/Smad pathway in an AMPKα-dependent manner. International Immunopharmacology. 120. 110369–110369. 4 indexed citations
3.
Zeng, Zhi, Li Xu, Xiaoyu Xie, et al.. (2020). Pulmonary pathology of early‐phase COVID‐19 pneumonia in a patient with a benign lung lesion. Histopathology. 77(5). 823–831. 62 indexed citations
4.
Huang, Jingyu, Aifen Wang, Ganjun Kang, Dejia Li, & Weidong Hu. (2020). Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery. Journal of Thoracic and Cardiovascular Surgery. 160(2). e91–e93. 6 indexed citations
5.
Chen, Qian, et al.. (2020). GDF-15 prevents lipopolysaccharide-mediated acute lung injury via upregulating SIRT1. Biochemical and Biophysical Research Communications. 526(2). 439–446. 21 indexed citations
6.
Zhang, Xinghua, Qian Chen, Wanli Jiang, et al.. (2020). MicroRNA‑375 prevents TGF‑β‑dependent transdifferentiation of lung fibroblasts via the MAP2K6/P38 pathway. Molecular Medicine Reports. 22(3). 1803–1810. 15 indexed citations
7.
Yuan, Wen, Jie Xiong, Wanli Jiang, et al.. (2020). Placenta‑derived mesenchymal stem cells ameliorate lipopolysaccharide‑induced inflammation in RAW264.7 cells and acute lung injury in rats. Molecular Medicine Reports. 22(2). 1458–1466. 8 indexed citations
8.
Cao, Yu, et al.. (2019). Knockdown of Sfrp4 attenuates apoptosis to protect against myocardial ischemia/reperfusion injury. Journal of Pharmacological Sciences. 140(1). 14–19. 29 indexed citations
9.
Zhang, Ying, et al.. (2019). Downregulation of lysyl oxidase‐like 4 LOXL4 by miR‐135a‐5p promotes lung cancer progression in vitro and in vivo. Journal of Cellular Physiology. 234(10). 18679–18687. 30 indexed citations
10.
Zeng, Wenhui, Wanli Jiang, Ganjun Kang, et al.. (2019). Colon Interposition for Corrosive Esophageal Stricture: Single Institution Experience with 119 Cases. Current Medical Science. 39(3). 415–418. 10 indexed citations
11.
Fan, Guohua, et al.. (2018). Predictive value of the thymofatty specimen weight index in outcomes of extended thymectomy due to non-thymomatous myasthenia gravis. Interactive Cardiovascular and Thoracic Surgery. 27(2). 290–294. 1 indexed citations
12.
Tu, Zhenbo, Songping Xie, Meng Xiong, et al.. (2016). CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. International Journal of Oncology. 50(2). 505–514. 32 indexed citations
13.
Xie, Songping, Zhenbo Tu, Jie Xiong, et al.. (2016). CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. Oncology Reports. 37(2). 921–928. 27 indexed citations
14.
15.
Xie, Songping, Ganjun Kang, Guohua Fan, Qing Geng, & Jie Huang. (2014). Ivor-Lewis esophagectomy for esophageal cancer after distal gastrectomy.. PubMed. 6(2). E22–6. 1 indexed citations
16.
Xie, Songping, Ganjun Kang, Guohua Fan, Wei Wang, & Jie Huang. (2013). Surgical Treatment of Synchronous Gastric and Esophageal Carcinoma: Case Report and Review of Literature. SHILAP Revista de lepidopterología. 2(1). 35–37. 2 indexed citations
17.
Kang, Ganjun, Wenyang Jiang, Songping Xie, & Jie Huang. (2013). VATS right upper lobectomy.. PubMed. 5 Suppl 3. S325–7. 1 indexed citations
18.
Chang, Sheng, et al.. (2008). [Clinicopathological analysis of esophageal carcinosarcoma:a report of 22 cases].. PubMed. 11(3). 235–7. 3 indexed citations
19.
Wang, Zhiwei, Xiaojian Wu, Hao Hu, et al.. (2006). [Surgical anatomy of the colic vessels in Chinese and its influence on the operation of esophageal replacement with colon].. PubMed. 86(21). 1453–6. 11 indexed citations
20.
Xia, Jun, et al.. (2004). Surgical treatment for giant solid tumors of the mediastinum: a study of 26 cases.. PubMed. 88(3). 164–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pei-Ying Wu Breakdown of academic impact, for papers by You Zou Breakdown of academic impact, for papers by Zhenhua Zhu Breakdown of academic impact, for papers by Panagiota Tsioli Breakdown of academic impact, for papers by Jieli Han Breakdown of academic impact, for papers by Eui‐Young So Breakdown of academic impact, for papers by Daqian Gu Breakdown of academic impact, for papers by Moe Matsumoto Breakdown of academic impact, for papers by Zhengrong Mao Breakdown of academic impact, for papers by Wenfeng Zhang
Rankless by CCL
2026